Literature DB >> 30869146

AIControl: replacing matched control experiments with machine learning improves ChIP-seq peak identification.

Naozumi Hiranuma1, Scott M Lundberg1, Su-In Lee1.   

Abstract

ChIP-seq is a technique to determine binding locations of transcription factors, which remains a central challenge in molecular biology. Current practice is to use a 'control' dataset to remove background signals from a immunoprecipitation (IP) 'target' dataset. We introduce the AIControl framework, which eliminates the need to obtain a control dataset and instead identifies binding peaks by estimating the distributions of background signals from many publicly available control ChIP-seq datasets. We thereby avoid the cost of running control experiments while simultaneously increasing the accuracy of binding location identification. Specifically, AIControl can (i) estimate background signals at fine resolution, (ii) systematically weigh the most appropriate control datasets in a data-driven way, (iii) capture sources of potential biases that may be missed by one control dataset and (iv) remove the need for costly and time-consuming control experiments. We applied AIControl to 410 IP datasets in the ENCODE ChIP-seq database, using 440 control datasets from 107 cell types to impute background signal. Without using matched control datasets, AIControl identified peaks that were more enriched for putative binding sites than those identified by other popular peak callers that used a matched control dataset. We also demonstrated that our framework identifies binding sites that recover documented protein interactions more accurately.
© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30869146      PMCID: PMC6547432          DOI: 10.1093/nar/gkz156

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  44 in total

1.  High-resolution profiling of histone methylations in the human genome.

Authors:  Artem Barski; Suresh Cuddapah; Kairong Cui; Tae-Young Roh; Dustin E Schones; Zhibin Wang; Gang Wei; Iouri Chepelev; Keji Zhao
Journal:  Cell       Date:  2007-05-18       Impact factor: 41.582

2.  Large-scale imputation of epigenomic datasets for systematic annotation of diverse human tissues.

Authors:  Jason Ernst; Manolis Kellis
Journal:  Nat Biotechnol       Date:  2015-02-18       Impact factor: 54.908

3.  ChIP-Seq data analysis: identification of protein-DNA binding sites with SISSRs peak-finder.

Authors:  Leelavati Narlikar; Raja Jothi
Journal:  Methods Mol Biol       Date:  2012

4.  Sequence and chromatin determinants of cell-type-specific transcription factor binding.

Authors:  Aaron Arvey; Phaedra Agius; William Stafford Noble; Christina Leslie
Journal:  Genome Res       Date:  2012-09       Impact factor: 9.043

5.  Global quantitative modeling of chromatin factor interactions.

Authors:  Jian Zhou; Olga G Troyanskaya
Journal:  PLoS Comput Biol       Date:  2014-03-27       Impact factor: 4.475

6.  Zinc finger independent genome-wide binding of Sp2 potentiates recruitment of histone-fold protein Nf-y distinguishing it from Sp1 and Sp3.

Authors:  Sara Völkel; Bastian Stielow; Florian Finkernagel; Thorsten Stiewe; Andrea Nist; Guntram Suske
Journal:  PLoS Genet       Date:  2015-03-20       Impact factor: 5.917

7.  JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework.

Authors:  Aziz Khan; Oriol Fornes; Arnaud Stigliani; Marius Gheorghe; Jaime A Castro-Mondragon; Robin van der Lee; Adrien Bessy; Jeanne Chèneby; Shubhada R Kulkarni; Ge Tan; Damir Baranasic; David J Arenillas; Albin Sandelin; Klaas Vandepoele; Boris Lenhard; Benoît Ballester; Wyeth W Wasserman; François Parcy; Anthony Mathelier
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

Review 8.  Transcriptional regulation by hypoxia inducible factors.

Authors:  Veronica L Dengler; Matthew Galbraith; Joaquín M Espinosa
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-10-07       Impact factor: 8.250

9.  HCFC1 is a common component of active human CpG-island promoters and coincides with ZNF143, THAP11, YY1, and GABP transcription factor occupancy.

Authors:  Joëlle Michaud; Viviane Praz; Nicole James Faresse; Courtney K Jnbaptiste; Shweta Tyagi; Frédéric Schütz; Winship Herr
Journal:  Genome Res       Date:  2013-03-28       Impact factor: 9.043

10.  Design and analysis of ChIP-seq experiments for DNA-binding proteins.

Authors:  Peter V Kharchenko; Michael Y Tolstorukov; Peter J Park
Journal:  Nat Biotechnol       Date:  2008-11-16       Impact factor: 54.908

View more
  4 in total

1.  F-Seq2: improving the feature density based peak caller with dynamic statistics.

Authors:  Nanxiang Zhao; Alan P Boyle
Journal:  NAR Genom Bioinform       Date:  2021-02-23

Review 2.  Exploitation of epigenetic variation of crop wild relatives for crop improvement and agrobiodiversity preservation.

Authors:  Serena Varotto; Tamar Krugman; Riccardo Aiese Cigliano; Khalil Kashkush; Ankica Kondić-Špika; Fillipos A Aravanopoulos; Monica Pradillo; Federica Consiglio; Riccardo Aversano; Ales Pecinka; Dragana Miladinović
Journal:  Theor Appl Genet       Date:  2022-06-09       Impact factor: 5.699

3.  Genome-Wide Chromatin Analysis of FFPE Tissues Using a Dual-Arm Robot with Clinical Potential.

Authors:  Syuzo Kaneko; Toutai Mitsuyama; Kouya Shiraishi; Noriko Ikawa; Kanto Shozu; Ai Dozen; Hidenori Machino; Ken Asada; Masaaki Komatsu; Asako Kukita; Kenbun Sone; Hiroshi Yoshida; Noriko Motoi; Shinya Hayami; Yutaka Yoneoka; Tomoyasu Kato; Takashi Kohno; Toru Natsume; Gottfried von Keudell; Vassiliki Saloura; Hiroki Yamaue; Ryuji Hamamoto
Journal:  Cancers (Basel)       Date:  2021-04-28       Impact factor: 6.639

4.  RECAP reveals the true statistical significance of ChIP-seq peak calls.

Authors:  Justin G Chitpin; Aseel Awdeh; Theodore J Perkins
Journal:  Bioinformatics       Date:  2019-10-01       Impact factor: 6.937

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.